DPP4 and diabetes mellitus: It can be targeted to the diabetes treatment in two different forms: (I) targeting the GLP-1 receptor itself, with an incretin mimetic with an extended half-life; or (II) targeting dipeptidyl peptidase 4 (DPP4) enzyme that acts by inactivating GLP-1.